BMAL1 and cancer: In cancer models where MYC is upregulated (by another oncogene or through circadian disruption), and is still circadian-controlled, MYC does not seem to exert a strong effect in suppressing BMAL1 and ablating rhythmicity of the molecular clock or downstream targets [11,17,43,81,82].